Because we now have so many alternatives for the long-term management of our patients with rheumatoid arthritis, corticosteroids should never be a first choice. However, they would be an acceptable alternative in patients failing first-line disease-modifying agents who cannot use biologic agents.
Interview by Diana Mahoney
Dr. Simon Carette is professor of medicine at the University of Toronto. In addition, he is head of the division of rheumatology at the University Health Network/Mount Sinai Hospital and director of the vasculitis clinic at the Rebecca MacDonald Center for Arthritis and Autoimmune Disease, all in Toronto as well. He reported having no relevant financial conflicts to disclose.